I just completed a regression analysis of the over 50 biotechnology parcels that I have purchased over the past several years. In 94% of all cases, every parcel appreciated prior to news of trial results, etc. being reported to the market place. In addition, 67% declined after news was reported (either positive or negative trial results). As I and Gassy have stated on numerous occasions, Innate is not trading any where near where it should be at this time prior to trial results. We have seen a steady decline in parcel pricing from around A$.76/share to A$.63/share (20% decline in less than 2 weeks). I challenge anyone here to convince me that this is not bad news coming. It appears that we may have been taken to the pond on this one!
- Forums
- ASX - By Stock
- ATX
- Biotech Appreciation Then Decline
Biotech Appreciation Then Decline
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
|
|||||
Last
6.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.38M |
Open | High | Low | Value | Volume |
6.3¢ | 6.4¢ | 6.3¢ | $3.016K | 47.79K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 217306 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.4¢ | 37701 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 217306 | 0.062 |
1 | 122950 | 0.061 |
3 | 39253 | 0.060 |
3 | 108326 | 0.059 |
3 | 100991 | 0.058 |
Price($) | Vol. | No. |
---|---|---|
0.064 | 37701 | 1 |
0.070 | 12509 | 2 |
0.075 | 335646 | 1 |
0.079 | 3000 | 1 |
0.080 | 200000 | 1 |
Last trade - 15.59pm 18/07/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |